Recently, Chen et al. (2023) demonstrated that APOE4/Tau mouse models experience detrimental brain atrophy compared to APOE3/Tau mice, and depleting microglia and/or T cells robustly reduced the observed atrophy (Chen et al., 2023). The gene discussed is MAPT; the disease is Brain atrophy.